These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 33300045)
1. Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma. Ross JL; Chen Z; Herting CJ; Grabovska Y; Szulzewsky F; Puigdelloses M; Monterroza L; Switchenko J; Wadhwani NR; Cimino PJ; Mackay A; Jones C; Read RD; MacDonald TJ; Schniederjan M; Becher OJ; Hambardzumyan D Brain; 2021 Feb; 144(1):53-69. PubMed ID: 33300045 [TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Doucette TA; Kong LY; Yang Y; Ferguson SD; Yang J; Wei J; Qiao W; Fuller GN; Bhat KP; Aldape K; Priebe W; Bögler O; Heimberger AB; Rao G Neuro Oncol; 2012 Sep; 14(9):1136-45. PubMed ID: 22753228 [TBL] [Abstract][Full Text] [Related]
3. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas. Herting CJ; Chen Z; Pitter KL; Szulzewsky F; Kaffes I; Kaluzova M; Park JC; Cimino PJ; Brennan C; Wang B; Hambardzumyan D Glia; 2017 Dec; 65(12):1914-1926. PubMed ID: 28836293 [TBL] [Abstract][Full Text] [Related]
4. 1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas. Zhang Y; Xie Y; He L; Tang J; He Q; Cao Q; Cui L; Guo W; Hua K; Dimberg A; Wang L; Zhang L Cell Oncol (Dordr); 2021 Feb; 44(1):193-204. PubMed ID: 32915415 [TBL] [Abstract][Full Text] [Related]
5. Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition. Rao R; Han R; Ogurek S; Xue C; Wu LM; Zhang L; Zhang L; Hu J; Phoenix TN; Waggoner SN; Lu QR Neuro Oncol; 2022 Apr; 24(4):584-597. PubMed ID: 34562087 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas. Dahlrot RH Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629 [TBL] [Abstract][Full Text] [Related]
7. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma. Zhou J; Pei X; Yang Y; Wang Z; Gao W; Ye R; Zhang X; Liu J; Liu Z; Yang X; Tao J; Gu C; Hu W; Chan FL; Li X; Mao J; Wu D J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858847 [TBL] [Abstract][Full Text] [Related]
9. Identification of the immune gene expression signature associated with recurrence of high-grade gliomas. Roura AJ; Gielniewski B; Pilanc P; Szadkowska P; Maleszewska M; Krol SK; Czepko R; Kaspera W; Wojtas B; Kaminska B J Mol Med (Berl); 2021 Feb; 99(2):241-255. PubMed ID: 33215304 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation. Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120 [TBL] [Abstract][Full Text] [Related]
11. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma. Pachocki CJ; Hol EM J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059 [TBL] [Abstract][Full Text] [Related]
12. Profiling hypoxia signaling reveals a lncRNA signature contributing to immunosuppression in high-grade glioma. Li X; Xu J; Li X; Shi J; Wei C; Liang Q Front Immunol; 2024; 15():1471388. PubMed ID: 39416790 [TBL] [Abstract][Full Text] [Related]
16. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845 [TBL] [Abstract][Full Text] [Related]
17. Chronic Stress Exacerbates the Immunosuppressive Microenvironment and Progression of Gliomas by Reducing Secretion of CCL3. Wang X; Zhang L; Zhou Y; Wang Y; Wang X; Zhang Y; Quan A; Mao Y; Zhang Y; Qi J; Ren Z; Gu L; Yu R; Zhou X Cancer Immunol Res; 2024 May; 12(5):516-529. PubMed ID: 38437646 [TBL] [Abstract][Full Text] [Related]
18. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact. Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238 [TBL] [Abstract][Full Text] [Related]
19. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. Paugh BS; Qu C; Jones C; Liu Z; Adamowicz-Brice M; Zhang J; Bax DA; Coyle B; Barrow J; Hargrave D; Lowe J; Gajjar A; Zhao W; Broniscer A; Ellison DW; Grundy RG; Baker SJ J Clin Oncol; 2010 Jun; 28(18):3061-8. PubMed ID: 20479398 [TBL] [Abstract][Full Text] [Related]
20. Breaking the feed forward inflammatory cytokine loop in the tumor microenvironment of PDGFB-driven glioblastomas. Miller CR; Hjelmeland AB J Clin Invest; 2023 Nov; 133(22):. PubMed ID: 37966120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]